Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three years.
Lansky, Alexandra J
Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three years. [electronic resource] - The American journal of cardiology Jul 2012 - 21-9 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1879-1913
10.1016/j.amjcard.2012.02.040 doi
Angioplasty, Balloon, Coronary--methods
Antineoplastic Agents, Phytogenic--pharmacology
Coronary Angiography--methods
Coronary Artery Disease--diagnostic imaging
Everolimus
Follow-Up Studies
Humans
Immunosuppressive Agents--pharmacology
Paclitaxel--pharmacology
Prospective Studies
Prosthesis Design
Reproducibility of Results
Single-Blind Method
Sirolimus--analogs & derivatives
Time Factors
Treatment Outcome
Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three years. [electronic resource] - The American journal of cardiology Jul 2012 - 21-9 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1879-1913
10.1016/j.amjcard.2012.02.040 doi
Angioplasty, Balloon, Coronary--methods
Antineoplastic Agents, Phytogenic--pharmacology
Coronary Angiography--methods
Coronary Artery Disease--diagnostic imaging
Everolimus
Follow-Up Studies
Humans
Immunosuppressive Agents--pharmacology
Paclitaxel--pharmacology
Prospective Studies
Prosthesis Design
Reproducibility of Results
Single-Blind Method
Sirolimus--analogs & derivatives
Time Factors
Treatment Outcome